571 related articles for article (PubMed ID: 24269619)
1. Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital.
Mills B; Fensterheim L; Taitel M; Cannon A
Vaccine; 2014 Jan; 32(4):521-5. PubMed ID: 24269619
[TBL] [Abstract][Full Text] [Related]
2. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
3. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
Thierry-Carstensen B; Jordan K; Uhlving HH; Dalby T; Sørensen C; Jensen AM; Heilmann C
Vaccine; 2012 Aug; 30(37):5464-71. PubMed ID: 22776216
[TBL] [Abstract][Full Text] [Related]
4. A behavioral economics intervention to increase pertussis vaccination among infant caregivers: A randomized feasibility trial.
Buttenheim AM; Fiks AG; Burson RC; Wang E; Coffin SE; Metlay JP; Feemster KA
Vaccine; 2016 Feb; 34(6):839-45. PubMed ID: 26686571
[TBL] [Abstract][Full Text] [Related]
5. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
[TBL] [Abstract][Full Text] [Related]
6. Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Jul; 57(29):796-9. PubMed ID: 18650787
[TBL] [Abstract][Full Text] [Related]
7. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection.
Castagnini LA; Healy CM; Rench MA; Wootton SH; Munoz FM; Baker CJ
Clin Infect Dis; 2012 Jan; 54(1):78-84. PubMed ID: 22075790
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of hospital-based postpartum procedures on pertussis vaccination among postpartum women.
Yeh S; Mink C; Kim M; Naylor S; Zangwill KM; Allred NJ
Am J Obstet Gynecol; 2014 Mar; 210(3):237.e1-6. PubMed ID: 24096180
[TBL] [Abstract][Full Text] [Related]
9. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
10. Pertussis vaccination in adult trauma patients: Are we missing an opportunity?
Yorkgitis BK; Timoney G; Salim A; Berg Pv; Goldberg AJ; Pathak A; Rappold JF
Surgery; 2015 Sep; 158(3):602-7. PubMed ID: 26032818
[TBL] [Abstract][Full Text] [Related]
11. Pertussis and patient safety: implementing Tdap vaccine recommendations in hospitals.
Tan TQ; Gerbie MV
Jt Comm J Qual Patient Saf; 2010 Apr; 36(4):173-8. PubMed ID: 20402374
[TBL] [Abstract][Full Text] [Related]
12. Predictors of tetanus-diphtheria- acellular pertussis vaccination among adults receiving tetanus vaccine in the United States: data from the 2008 national health interview survey.
Johns TL; Roetzheim R; Chen R
J Prim Care Community Health; 2013 Apr; 4(2):95-100. PubMed ID: 23799715
[TBL] [Abstract][Full Text] [Related]
13. Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(40):1302-6. PubMed ID: 20948508
[TBL] [Abstract][Full Text] [Related]
14. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1424-6. PubMed ID: 22012116
[TBL] [Abstract][Full Text] [Related]
15. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
Dylag AM; Shah SI
Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
[TBL] [Abstract][Full Text] [Related]
16. Protecting newborns by immunizing family members in a hospital-based vaccine clinic: a successful Tdap cocooning program during the 2010 California pertussis epidemic.
Rosenblum E; McBane S; Wang W; Sawyer M
Public Health Rep; 2014 May; 129(3):245-51. PubMed ID: 24791022
[TBL] [Abstract][Full Text] [Related]
17. A quality improvement initiative to increase Tdap (tetanus, diphtheria, acellular pertussis) vaccination coverage among direct health care providers at a children's hospital.
Jiang C; Whitmore-Sisco L; Gaur AH; Adderson EE;
Vaccine; 2018 Jan; 36(2):214-219. PubMed ID: 29217370
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.
Terranella A; Asay GR; Messonnier ML; Clark TA; Liang JL
Pediatrics; 2013 Jun; 131(6):e1748-56. PubMed ID: 23713104
[TBL] [Abstract][Full Text] [Related]
19. Implementation of pertussis immunization in health-care personnel.
Walther K; Burckhardt MA; Erb T; Heininger U
Vaccine; 2015 Apr; 33(17):2009-14. PubMed ID: 25776922
[TBL] [Abstract][Full Text] [Related]
20. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
